Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Squamous Cell Carcinoma of Head and Neck 11Nasopharyngeal Carcinoma 6Oropharyngeal Neoplasms 5Prostatic Neoplasms 4Laryngeal Neoplasms 4Carcinoma 4Mouth Neoplasms 3Hypopharyngeal Neoplasms 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Mesothelioma 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Anus Neoplasms 2Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Stomatitis 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Salivary Gland Neoplasms 1PSA Level Greater Than Two 1Oligodendroglioma 1Mesothelioma, Malignant 1Meningioma 1Lymphoma, Follicular 1Lymphoid Interstitial Pneumonia 1Locally Advanced Cervical Adenocarcinoma 1HIV Infections 1Glioma 1Glioblastoma 1

Interventions

Specimen Handling 16Magnetic Resonance Spectroscopy 15Gemcitabine 14pembrolizumab 11Cisplatin 11Mitomycin 7Radiation 6Fluorouracil 6Cystoscopy 6enfortumab vedotin 5avelumab 5Biopsy 5dehydroftorafur 4Transurethral Resection of Bladder 4Radiotherapy 4Platinum 4Nivolumab 4Mitozytrex 4Carboplatin 41,2-diaminocyclohexaneplatinum II citrate 4erdafitinib 3durvalumab 3cabozantinib 3Immunoglobulin G 3Disulfides 3sapanisertib 2olaparib 2eribulin 2atezolizumab 2Surveys and Questionnaires 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Radiotherapy, Intensity-Modulated × 30 days × Clear all
NCT02316548 2026-05-22

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

NRG Oncology

Phase 2 Terminated
14 enrolled 16 charts
Genitourinary

Urinary Bladder Neoplasms

NCT07579195 2026-05-14

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

University of Washington

Phase 1/2 Not yet recruiting
12 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡